, China

California filmmaker seeks $500m in Hong Kong IPO

STX Entertainment seeks to capture China’s vast moviegoing market.

Bloomberg reports that California-based movie studio STX Entertainment has filed for a Hong Kong initial public offering in a deal that could raise as much as $500m.

STX Entertainment is the studio behind films like Bad Moms and The Great Wall and is backed by big-time investors including Tencent Holdings Ltd., TPG, Hony Capital and Hong Kong billionaire Richard Li’s PCCW Ltd.

The studio is hoping to tap on the vast Chinese moviegoing audience which is projected to be the largest global box-office market by 2021 with ticket sales in the country steadily growing at a 17.1% compound annual rate.

By co-producing films with Chinese studios, STX hopes to partake in China’s profitable box office market especially since joint productions aren't subject to a quota of 34 films a year that the government imposes on Hollywood movies screened in China.

Here’s more from Bloomberg

Join Hong Kong Business community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

Hong Kong and Shanghai to enhance financial ties
The two cities will leverage on their competitive advantage to boost their financial cooperation.
HK Express load factors exceed 97% in April amidst Easter holidays
Current bookings to North Asian destinations exceed 90% occupancy as Golden Week approaches.
Aviation
PolyU partners with ZEISS for myopia control tech advancement
The partnership focuses on developing myopia control and other ophthalmic technologies.
Healthcare